Organism name | Brassica hirta |
---|---|
Genus | Brassica |
Family | Cruciferae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Sinapis alba |
---|---|
Linked NCBI taxonomy ID | 3728 |
Linked level | species |
Family in NCBI taxonomy | Brassicaceae |
---|---|
ID | 3700 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | rosids |
---|---|
ID | 71275 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00001488
![]() |
Sinigrin
/ Allyl glucosinolate / 2-Phenylethyl glucosinolate |
No. 46 | No. 76 |
![]() |
||||
C00001479
![]() |
Glucoputranjivin
/ isopropyl glucosinolate / 1-Methylethyl glucosinolate |
CHEMBL2208210
|
No. 46 | No. 76 |
![]() |
|||
C00030958
![]() |
Pentacosane
|
No. 115 |
![]() |
|||||
C00032307
![]() |
Tetracosane
/ n-Tetracosane |
No. 115 |
![]() |
|||||
C00030471
![]() |
Heptacosane
|
No. 115 |
![]() |
|||||
C00030478
![]() |
Hexacosane
|
No. 115 |
![]() |
|||||
C00007350
![]() |
Gluconasturtiin
/ 2-Phenylethylglucosinolate |
C443697
|
No. 158 | No. 77 |
![]() |
|||
C00001487
![]() |
Sinalbin
|
C003313
|
No. 158 | No. 77 |
![]() |
|||
C00007423
![]() |
Pentadecanoic acid
/ n-Pentadecanoic acid |
CHEMBL460025
|
1 / 2 / 2 | No. 184 | No. 68 |
![]() |
||
C00001238
![]() |
Stearic acid
|
CHEMBL46403
|
C031183
|
15 / 17 / 19 | 6 / 1 | No. 184 | No. 68 |
![]() |
C00029354
![]() |
Palmitoleic acid
/ cis-Palmitoleic acid / (Z)-Palmitoleic acid |
CHEMBL453509
|
2 / 5 / 3 | No. 184 | No. 68 |
![]() |
||
C00007426
![]() |
Margaric acid
/ Heptadecanoic acid |
CHEMBL1172910
|
C013102
|
No. 184 | No. 68 |
![]() |
||
C00001233
![]() |
Palmitic acid
|
CHEMBL82293
|
D019308
|
16 / 8 / 8 | 35 / 1 | No. 184 | No. 68 |
![]() |
C00001232
![]() |
Oleic acid
/ (Z)-9-Octadecenoic acid |
CHEMBL8659
CHEMBL460657 |
D019301
|
30 / 19 / 20 | 26 / 9 | No. 184 | No. 68 |
![]() |
C00020065
![]() |
alpha-Cadinol
/ (-)-alpha-Cadinol |
CHEMBL486795
|
No. 205 | No. 38 |
![]() |
|||
C00020154
![]() |
T-Muurolol
/ epi-alpha-Muurolol |
CHEMBL486795
|
No. 205 | No. 38 |
![]() |
|||
C00031285
![]() |
Sandaracopimarinol
|
No. 208 | No. 48 |
![]() |
||||
C00001224
![]() |
Linoleic acid
/ (Z,Z)-9,12-Octadecadienoic acid |
CHEMBL267476
|
29 / 31 / 28 | No. 367 | No. 68 |
![]() |
||
C00030755
![]() |
Methyl palmitate
/ Methyl hexadecanoate |
CHEMBL335125
|
C019012
|
2 / 0 / 0 | 0 / 1 | No. 793 |
![]() |
|
C00032443
![]() |
Undecane
|
CHEMBL132474
|
C022884
|
No. 877 |
![]() |
|||
C00030100
![]() |
Decanol
/ 1-Decanol / n-Decanol |
CHEMBL25363
|
C029383
|
1 / 0 / 0 | 1 / 0 | No. 877 |
![]() |
|
C00029809
![]() |
Benzenepropanenitrile
|
No. 885 |
![]() |
|||||
C00002663
![]() |
2-Phenylethanol
/ Phenethyl alcohol / Phenylethyl alcohol / beta-Phenethyl alcohol |
CHEMBL448500
|
D010626
|
2 / 1 / 1 | No. 885 |
![]() |
||
C00007535
![]() |
Phenylacetaldehyde
/ Benzeneacetaldehyde / Phenylacetic aldehyde |
C013192
|
3 / 0 | No. 885 |
![]() |
|||
C00029532
![]() |
4-Hydroxybenzyl cyanide
/ p-Hydroxyphenylacetonitrile / 4-Hydroxy-benzeneacetonitrile |
C026914
|
No. 936 | No. 6 |
![]() |
|||
C00001221
![]() |
Lauric acid
/ Docosanoic acid / n-Dodecanoic acid |
CHEMBL108766
|
C030358
|
19 / 25 / 14 | 11 / 0 | No. 1141 | No. 68 |
![]() |
C00001213
![]() |
Capric acid
/ Decanoic acid / n-Decanoic acid |
CHEMBL107498
|
C031071
|
8 / 11 / 6 | 4 / 0 | No. 1141 | No. 68 |
![]() |
C00030829
![]() |
Pelargonic acid
/ n-Nonanoic acid |
CHEMBL108436
|
C008776
|
4 / 4 / 2 | 3 / 1 | No. 1141 | No. 68 |
![]() |
C00001228
![]() |
Myristic acid
/ Tetradecanoic acid / n-Tetradecanoic acid |
CHEMBL111077
|
D019814
|
17 / 9 / 10 | 3 / 0 | No. 1141 | No. 68 |
![]() |
C00001231
![]() |
Caprylic acid
/ Octanoic acid / n-Octanoic acid |
CHEMBL324846
|
C031492
|
10 / 14 / 13 | 2 / 1 | No. 1141 | No. 68 |
![]() |
C00001318
![]() |
gamma-Nonalactone
|
CHEMBL191935
|
3 / 3 / 1 | No. 1374 |
![]() |
|||
C00002741
![]() |
Methyleugenol
/ 4-Allylveratrole / Eugenol methyl ether |
CHEMBL108861
|
C005223
|
12 / 13 / 9 | 3 / 9 | No. 1412 |
![]() |
|
C00002704
![]() |
Paeonol
|
CHEMBL1079227
|
C013638
|
4 / 2 / 3 | No. 1494 |
![]() |
||
C00030878
![]() |
o-Cresol
|
CHEMBL46931
|
C034047
|
4 / 9 / 3 | 1 / 4 | No. 1546 |
![]() |
|
C00002645
![]() |
p-Cresol
/ 4-Methylphenol |
CHEMBL16645
|
C032538
|
8 / 4 / 4 | 10 / 4 | No. 1546 |
![]() |
|
C00030830
![]() |
Nonanol
/ n-Nonanol |
CHEMBL24563
|
C014713
|
1 / 0 | No. 1749 |
![]() |
||
C00030757
![]() |
Methyl linoleate
/ Methyl 9Z,12Z-octadecadienoate |
C005575
|
No. 1785 |
![]() |
||||
C00030760
![]() |
Methyl oleate
/ Oleic acid methyl ester / Methyl (Z)-9-octadecenoate |
CHEMBL465725
|
C005576
|
2 / 6 / 5 | No. 1785 |
![]() |
||
C00030223
![]() |
Nikkol VF-E
/ Ethyl linoleate |
CHEMBL2106238
|
C007678
|
No. 1785 |
![]() |
|||
C00000619
![]() |
Eugenol
|
CHEMBL42710
|
D005054
|
103 / 45 / 36 | 152 / 28 | No. 1852 | No. 6 |
![]() |
C00003046
![]() |
Geranyl acetate
/ trans-Geranyl acetate / Acetic acid geraniol ester |
CHEMBL1369384
|
5 / 3 / 4 | No. 2157 | No. 34 |
![]() |
||
C00000207
![]() |
Benzoic acid
|
CHEMBL541
|
D019817
|
97 / 39 / 33 | 24 / 1 | No. 2192 |
![]() |
|
C00002654
![]() |
Guaiacol
/ o-Guaiacol |
CHEMBL13766
|
D006139
|
15 / 18 / 47 | 3 / 1 | No. 2352 |
![]() |
|
C00029334
![]() |
(E)-Anethol
/ trans-Anethol / trans-1-(4-Methoxyphenyl)-1-propene |
CHEMBL452630
CHEMBL1468832 |
6 / 21 / 49 | No. 2748 | No. 6 |
![]() |
||
C00029316
![]() |
(2E)-Octenal
/ (E)-2-Octenal / trans-Oct-2-en-1-al |
CHEMBL448058
|
No. 2883 |
![]() |
||||
C00000351
![]() |
trans-2-Hexenal
|
No. 2883 |
![]() |
|||||
C00000357
![]() |
Hexanal
|
CHEMBL280331
|
C010463
|
7 / 0 | No. 3593 |
![]() |
||
C00001418
![]() |
Indole
|
CHEMBL15844
|
C030374
|
13 / 5 / 6 | 6 / 0 | No. 3673 |
![]() |
|
C00001180
![]() |
Butyric acid
|
CHEMBL14227
|
D020148
|
12 / 3 / 2 | 40 / 5 | No. 3692 | No. 68 |
![]() |
C00001218
![]() |
Caproic acid
/ Hexanoic acid / 1-Hexanoic acid / n-Hexanoic acid |
CHEMBL14184
|
C037652
|
5 / 0 / 0 | No. 3692 | No. 68 |
![]() |
|
C00029371
![]() |
2-Acetylfuran
|
CHEMBL75854
|
C039669
|
No. 3696 | No. 7 |
![]() |
||
C00029456
![]() |
2-Furanmethanol
/ alpha-Furylcarbinol |
CHEMBL308187
|
C012986
|
0 / 5 | No. 5208 |
![]() |
||
C00000136
![]() |
1,8-Cineole
|
CHEMBL485259
CHEMBL1397305 |
99 / 57 / 50 | No. 5413 | No. 35 |
![]() |
||
C00030331
![]() |
Furfural:2-Furaldehyde
|
CHEMBL189362
|
D005662
|
3 / 0 / 0 | No. 5758 |
![]() |
||
C00030540
![]() |
Isophorone
|
CHEMBL1882894
|
C005940
|
1 / 5 / 3 | 0 / 1 | No. 5881 |
![]() |
|
C00029580
![]() |
Sulcatol
/ 6-Methyl-5-hepten-2-ol |
C009344
|
No. 7354 |
![]() |
||||
C00029432
![]() |
Pyranone
/ 2,3-Dihydro-3,5-dihydroxy-6-methyl-4H-pyran-4-one |
No. 8702 |
![]() |
|||||
C00029449
![]() |
2-Acetyl pyrrole
/ 2-Acetyl-1H-indole / 2-Acetyl-1H-pyrrole |
CHEMBL1414126
|
C051267
|
No. 8895 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
O75496 | Geminin | Unclassified protein | C00000136 C00000619 C00001213 C00001224 C00001228 C00001231 C00001232 C00001233 C00002663 C00030829 | 0 / 0 |
P10275 | Androgen receptor | NR3C4 | C00000136 C00000619 C00001221 C00001224 C00001233 C00002645 C00002654 C00002741 C00003046 C00030760 | 3 / 4 |
Q96RI1 | Bile acid receptor | NR1H4 | C00001221 C00001224 C00001228 C00001232 C00001233 C00002741 C00003046 C00030100 C00030878 | 0 / 0 |
P16473 | Thyrotropin receptor | Glycohormone receptor | C00000136 C00000207 C00001213 C00001221 C00001224 C00001231 C00001238 C00002654 C00029334 | 3 / 2 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00000619 C00001221 C00001224 C00001231 C00002704 C00002741 C00003046 C00029334 C00030331 | 0 / 0 |
P04150 | Glucocorticoid receptor | NR3C1 | C00000136 C00000207 C00000619 C00001213 C00001231 C00001233 C00001238 C00002741 | 0 / 1 |
Q9HAW9 | UDP-glucuronosyltransferase 1-8 | Enzyme | C00000619 C00001180 C00001213 C00001218 C00001221 C00001228 C00001231 | 0 / 0 |
P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | C00001213 C00001221 C00001224 C00001232 C00002741 C00029354 C00030540 | 5 / 3 |
Q9HAW8 | UDP-glucuronosyltransferase 1-10 | Enzyme | C00000619 C00001180 C00001213 C00001218 C00001221 C00001228 C00001231 | 0 / 0 |
P03372 | Estrogen receptor | NR3A1 | C00000136 C00000207 C00000619 C00001221 C00001224 C00001233 | 1 / 1 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00001318 C00002645 C00002654 C00002741 C00003046 C00030878 | 0 / 0 |
P10828 | Thyroid hormone receptor beta | NR1A2 | C00001221 C00001238 C00001318 C00002741 C00030760 C00030829 | 3 / 1 |
P51449 | Nuclear receptor ROR-gamma | Nuclear hormone receptor subfamily 1 group F member 3 | C00001213 C00001221 C00001232 C00002645 C00002654 C00030331 | 0 / 0 |
P11511 | Cytochrome P450 19A1 | Cytochrome P450 19A1 | C00001224 C00001228 C00001232 C00001233 C00001238 C00007423 | 2 / 2 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00000136 C00000207 C00000619 C00001224 C00002704 C00029334 | 0 / 1 |
P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00000136 C00000207 C00000619 C00001232 C00001238 | 0 / 0 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00001218 C00001221 C00001224 C00001232 C00001238 | 0 / 0 |
P00918 | Carbonic anhydrase 2 | Lyase | C00000136 C00000207 C00000619 C00001418 C00002654 | 1 / 2 |
Q9UGP5 | DNA polymerase lambda | Enzyme | C00001218 C00001221 C00001224 C00001232 C00001238 | 0 / 0 |
Q07869 | Peroxisome proliferator-activated receptor alpha | NR1C1 | C00001224 C00001228 C00001232 C00001233 C00002741 | 0 / 0 |
P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00000136 C00000207 C00000619 C00030755 | 0 / 0 |
P17252 | Protein kinase C alpha type | Alpha | C00000136 C00000207 C00000619 C00001232 | 0 / 0 |
P03956 | Interstitial collagenase | M10A | C00000136 C00000207 C00000619 C00002654 | 0 / 1 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00000136 C00000207 C00000619 C00001224 | 0 / 0 |
P14780 | Matrix metalloproteinase-9 | M10A | C00000136 C00000207 C00000619 C00002654 | 2 / 2 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00000136 C00000207 C00000619 C00001318 | 0 / 0 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00000136 C00000207 C00000619 C00001232 | 2 / 2 |
P22303 | Acetylcholinesterase | Hydrolase | C00000136 C00000207 C00000619 C00002645 | 1 / 0 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | C00000136 C00001221 C00001228 C00001232 | 0 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00000136 C00000207 C00000619 C00002704 | 0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | C00000136 C00001224 C00001231 C00029334 | 11 / 10 |
P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00000136 C00000207 C00000619 C00001221 | 0 / 0 |
P15090 | Fatty acid-binding protein, adipocyte | Other cytosolic protein | C00001224 C00001232 C00001233 C00001238 | 0 / 0 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00001224 C00001228 C00001238 C00002663 | 1 / 1 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00001224 C00001228 C00001232 C00002741 | 0 / 0 |
P30988 | Calcitonin receptor | Calcitonin receptor | C00000136 C00000207 C00000619 | 0 / 0 |
P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00000136 C00000207 C00000619 | 0 / 1 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00000136 C00000207 C00000619 | 1 / 1 |
P25021 | Histamine H2 receptor | Histamine receptor | C00000136 C00000207 C00000619 | 0 / 0 |
P35367 | Histamine H1 receptor | Histamine receptor | C00000136 C00000207 C00000619 | 0 / 0 |
Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00000136 C00000207 C00000619 | 1 / 0 |
P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00000136 C00000207 C00000619 | 0 / 0 |
P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00000136 C00000207 C00000619 | 0 / 0 |
P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00000136 C00000207 C00000619 | 0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00000136 C00000207 C00000619 | 1 / 1 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00001224 C00001238 C00003046 | 0 / 0 |
P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00000136 C00000207 C00000619 | 0 / 0 |
P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00000136 C00000207 C00000619 | 0 / 0 |
P25105 | Platelet-activating factor receptor | PAF receptor | C00000136 C00000207 C00000619 | 0 / 0 |
P06241 | Tyrosine-protein kinase Fyn | Src | C00000136 C00000207 C00000619 | 0 / 0 |
Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00000136 C00000207 C00000619 | 0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00000136 C00000207 C00000619 | 0 / 1 |
P25103 | Substance-P receptor | Neurokinin receptor | C00000136 C00000207 C00000619 | 0 / 0 |
P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00000136 C00000207 C00000619 | 0 / 0 |
P35372 | Mu-type opioid receptor | Opioid receptor | C00000136 C00000207 C00000619 | 0 / 0 |
P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00000136 C00000207 C00000619 | 0 / 0 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00000136 C00000207 C00000619 | 1 / 8 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00000136 C00000207 C00000619 | 0 / 0 |
P05413 | Fatty acid-binding protein, heart | Other cytosolic protein | C00001224 C00001232 C00001233 | 0 / 0 |
P14416 | D(2) dopamine receptor | Dopamine receptor | C00000136 C00000207 C00000619 | 2 / 0 |
Q03181 | Peroxisome proliferator-activated receptor delta | NR1C2 | C00001224 C00002741 C00030331 | 0 / 0 |
P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00000136 C00000207 C00000619 | 0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | C00000136 C00000207 C00000619 | 0 / 0 |
Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00000136 C00000207 C00000619 | 0 / 0 |
P29274 | Adenosine receptor A2a | Adenosine receptor | C00000136 C00000207 C00000619 | 0 / 0 |
P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00000136 C00000207 C00000619 | 1 / 0 |
P27361 | Mitogen-activated protein kinase 3 | Erk | C00000136 C00000207 C00000619 | 0 / 0 |
P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00000136 C00000207 C00000619 | 0 / 0 |
P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00000136 C00000207 C00000619 | 1 / 1 |
O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00000136 C00000207 C00000619 | 0 / 0 |
P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00000136 C00000207 C00000619 | 0 / 0 |
P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00000136 C00000207 C00000619 | 1 / 0 |
P29466 | Caspase-1 | C14 | C00000136 C00000207 C00000619 | 0 / 0 |
P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00000136 C00000207 C00000619 | 0 / 0 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00001232 C00002654 C00002741 | 0 / 0 |
P30542 | Adenosine receptor A1 | Adenosine receptor | C00000136 C00000207 C00000619 | 0 / 0 |
P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00000136 C00000207 C00000619 | 0 / 0 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00001224 C00001232 C00001238 | 3 / 3 |
P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00000136 C00000207 C00000619 | 0 / 0 |
Q16539 | Mitogen-activated protein kinase 14 | p38 | C00000136 C00000207 C00000619 | 0 / 0 |
P33765 | Adenosine receptor A3 | Adenosine receptor | C00000136 C00000207 C00000619 | 0 / 0 |
P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00000136 C00000207 C00000619 | 2 / 1 |
P08246 | Neutrophil elastase | S1A | C00000136 C00000207 C00000619 | 2 / 1 |
O60656 | UDP-glucuronosyltransferase 1-9 | Enzyme | C00000207 C00000619 C00002645 | 0 / 0 |
P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00000136 C00000207 C00000619 | 1 / 0 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00000136 C00000207 C00000619 | 0 / 3 |
P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00000136 C00000207 C00000619 | 0 / 0 |
P21917 | D(4) dopamine receptor | Dopamine receptor | C00000136 C00000207 C00000619 | 0 / 0 |
P19224 | UDP-glucuronosyltransferase 1-6 | Enzyme | C00000207 C00000619 C00002645 | 0 / 0 |
P35462 | D(3) dopamine receptor | Dopamine receptor | C00000136 C00000207 C00000619 | 1 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | C00000136 C00000207 C00000619 | 0 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | C00000136 C00000207 C00000619 | 0 / 1 |
P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00000136 C00000207 C00000619 | 0 / 0 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | C00000136 C00000207 C00000619 | 0 / 0 |
P25101 | Endothelin-1 receptor | Endothelin receptor | C00000136 C00000207 C00000619 | 0 / 0 |
P30411 | B2 bradykinin receptor | Bradykinin receptor | C00000136 C00000207 C00000619 | 0 / 0 |
P10145 | Interleukin-8 | Secreted protein | C00000619 C00001221 C00002645 | 0 / 0 |
P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00000136 C00000207 C00000619 | 1 / 0 |
P13726 | Tissue factor | Membrane receptor | C00001224 C00001232 C00029354 | 0 / 0 |
P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00000136 C00000207 C00000619 | 0 / 0 |
P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00000136 C00000207 C00000619 | 0 / 0 |
P08311 | Cathepsin G | S1A | C00000136 C00000207 C00000619 | 0 / 0 |
Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00000136 C00000207 C00000619 | 1 / 0 |
P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00000136 C00000207 C00000619 | 3 / 0 |
P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00000136 C00000207 C00000619 | 0 / 0 |
P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00000136 C00000207 C00000619 | 0 / 0 |
P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00000136 C00000207 C00000619 | 0 / 0 |
P21452 | Substance-K receptor | Neurokinin receptor | C00000136 C00000207 C00000619 | 0 / 0 |
P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00000136 C00000207 C00000619 | 1 / 0 |
P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00000136 C00000207 C00000619 | 1 / 1 |
P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00000136 C00000207 C00000619 | 5 / 9 |
P06239 | Tyrosine-protein kinase Lck | Src | C00000136 C00000207 C00000619 | 0 / 1 |
P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00000136 C00000207 C00000619 | 0 / 0 |
P31645 | Sodium-dependent serotonin transporter | Serotonin | C00000136 C00000207 C00000619 | 2 / 0 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00001224 C00001232 C00001233 | 0 / 0 |
P22310 | UDP-glucuronosyltransferase 1-4 | Enzyme | C00000619 C00001213 C00001221 | 3 / 0 |
P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00000136 C00000207 C00000619 | 2 / 0 |
P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00000136 C00000207 C00000619 | 0 / 0 |
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00000136 C00000207 C00000619 | 1 / 0 |
P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00000136 C00000207 C00000619 | 1 / 1 |
Q13148 | TAR DNA-binding protein 43 | Unclassified protein | C00001228 C00030829 | 1 / 1 |
P35610 | Sterol O-acyltransferase 1 | Enzyme | C00001224 C00001232 | 0 / 0 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00001232 C00001238 | 1 / 2 |
P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | C00001221 C00030878 | 7 / 3 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | C00002654 C00029334 | 7 / 37 |
O60603 | Toll-like receptor 2 | Membrane receptor | C00001228 C00001233 | 1 / 1 |
P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00001221 C00001228 | 0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00000136 C00001232 | 4 / 3 |
P00915 | Carbonic anhydrase 1 | Lyase | C00001418 C00002654 | 0 / 0 |
P19793 | Retinoic acid receptor RXR-alpha | NR2B1 | C00001221 C00001224 | 0 / 0 |
P11387 | DNA topoisomerase 1 | Isomerase | C00001232 C00001233 | 0 / 0 |
P11473 | Vitamin D3 receptor | NR1I1 | C00001228 C00001238 | 2 / 3 |
P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00001224 C00002704 | 2 / 2 |
Q01469 | Fatty acid-binding protein, epidermal | Other cytosolic protein | C00001232 C00001233 | 0 / 0 |
P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00002741 C00030878 | 2 / 0 |
O94956 | Solute carrier organic anion transporter family member 2B1 | Unclassified protein | C00000207 | 0 / 0 |
Q8TCC7 | Solute carrier family 22 member 8 | Antiporter | C00001231 | 0 / 0 |
P54855 | UDP-glucuronosyltransferase 2B15 | Enzyme | C00000619 | 0 / 0 |
Q7Z4W1 | L-xylulose reductase | Enzyme | C00001180 | 0 / 1 |
P08253 | 72 kDa type IV collagenase | M10A | C00002654 | 1 / 3 |
P55055 | Oxysterols receptor LXR-beta | NR1H3 | C00000136 | 0 / 0 |
P35236 | Tyrosine-protein phosphatase non-receptor type 7 | Tyr | C00001224 | 0 / 0 |
P39748 | Flap endonuclease 1 | Enzyme | C00001228 | 0 / 0 |
P07148 | Fatty acid-binding protein, liver | Unclassified protein | C00001232 | 0 / 0 |
Q13133 | Oxysterols receptor LXR-alpha | NR1H3 | C00000136 | 0 / 0 |
Q9UQL6 | Histone deacetylase 5 | Hydrolase | C00001180 | 0 / 0 |
P17405 | Sphingomyelin phosphodiesterase | Enzyme | C00001228 | 2 / 2 |
Q92769 | Histone deacetylase 2 | Hydrolase | C00001180 | 0 / 0 |
Q9Y4X1 | UDP-glucuronosyltransferase 2A1 | Enzyme | C00000619 | 0 / 0 |
O15296 | Arachidonate 15-lipoxygenase B | Enzyme | C00001228 | 0 / 0 |
P23280 | Carbonic anhydrase 6 | Lyase | C00001418 | 0 / 0 |
P34972 | Cannabinoid receptor 2 | Cannabinoid receptor | C00030755 | 0 / 0 |
O15379 | Histone deacetylase 3 | Hydrolase | C00001180 | 0 / 0 |
P15121 | Aldose reductase | Enzyme | C00001218 | 0 / 0 |
P54132 | Bloom syndrome protein | Enzyme | C00001232 | 1 / 2 |
P14920 | D-amino-acid oxidase | Enzyme | C00000207 | 0 / 0 |
Q15078 | Cyclin-dependent kinase 5 activator 1 | REG serine/threonine protein kinase family | C00001418 | 0 / 0 |
Q00535 | Cyclin-dependent kinase 5 | Cdk5 | C00001418 | 0 / 0 |
Q9UQ49 | Sialidase-3 | Enzyme | C00000207 | 0 / 0 |
P08183 | Multidrug resistance protein 1 | drug | C00001233 | 1 / 0 |
P56524 | Histone deacetylase 4 | Hydrolase | C00001180 | 1 / 1 |
P19838 | Nuclear factor NF-kappa-B p105 subunit | Transcription Factor | C00001238 | 0 / 0 |
P51452 | Dual specificity protein phosphatase 3 | Ser_Thr_Tyr | C00001224 | 0 / 0 |
Q8WUI4 | Histone deacetylase 7 | Hydrolase | C00001180 | 0 / 0 |
Q9BY41 | Histone deacetylase 8 | Hydrolase | C00001180 | 2 / 0 |
P12104 | Fatty acid-binding protein, intestinal | Other cytosolic protein | C00001233 | 0 / 0 |
P08047 | Transcription factor Sp1 | Unclassified protein | C00001233 | 0 / 0 |
O14842 | Free fatty acid receptor 1 | Free fatty acid receptor | C00001224 | 0 / 0 |
O75164 | Lysine-specific demethylase 4A | Enzyme | C00001232 | 0 / 0 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00001232 | 0 / 0 |
P22309 | UDP-glucuronosyltransferase 1-1 | Enzyme | C00000619 | 5 / 1 |
O00519 | Fatty-acid amide hydrolase 1 | Enzyme | C00001232 | 0 / 0 |
Q99489 | D-aspartate oxidase | Enzyme | C00000207 | 0 / 0 |
Q13315 | Serine-protein kinase ATM | Atypical serine/threonine protein kinase PIKK subfamily | C00001232 | 1 / 4 |
Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00030829 | 0 / 0 |
Q13547 | Histone deacetylase 1 | Hydrolase | C00001180 | 0 / 0 |
Q05193 | Dynamin-1 | Structural | C00001228 | 0 / 0 |
P22894 | Neutrophil collagenase | M10A | C00002654 | 0 / 0 |
P09917 | Arachidonate 5-lipoxygenase | Oxidoreductase | C00002654 | 0 / 0 |
Q7Z2W7 | Transient receptor potential cation channel subfamily M member 8 | Unclassified protein | C00000136 | 0 / 0 |
P50225 | Sulfotransferase 1A1 | Enzyme | C00002645 | 0 / 0 |
O75795 | UDP-glucuronosyltransferase 2B17 | Enzyme | C00000619 | 1 / 0 |
P55263 | Adenosine kinase | Enzyme | C00001418 | 1 / 0 |
P08254 | Stromelysin-1 | M10A | C00002654 | 1 / 0 |
Q9UBN7 | Histone deacetylase 6 | Hydrolase | C00001180 | 0 / 0 |
P23141 | Liver carboxylesterase 1 | Enzyme | C00001418 | 0 / 0 |
Q9UKV0 | Histone deacetylase 9 | Hydrolase | C00001180 | 0 / 0 |
P22748 | Carbonic anhydrase 4 | Lyase | C00001418 | 1 / 1 |
Q9GZT4 | Serine racemase | Enzyme | C00000207 | 0 / 0 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00029334 | 0 / 0 |
P46063 | ATP-dependent DNA helicase Q1 | Enzyme | C00000136 | 0 / 0 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00002654 | 0 / 0 |
Q4U2R8 | Solute carrier family 22 member 6 | Antiporter | C00001231 | 0 / 0 |
O00255 | Menin | Unclassified protein | C00001238 | 2 / 5 |
P05107 | Integrin beta-2 | Membrane receptor | C00001418 | 1 / 1 |
P05362 | Intercellular adhesion molecule 1 | Adhesion | C00001418 | 1 / 2 |
P20701 | Integrin alpha-L | Membrane receptor | C00001418 | 0 / 0 |
Q9NSA0 | Solute carrier family 22 member 11 | Transporter | C00001231 | 0 / 0 |
P49840 | Glycogen synthase kinase-3 alpha | Gsk | C00001418 | 0 / 0 |
P49841 | Glycogen synthase kinase-3 beta | Gsk | C00001418 | 0 / 0 |
Q9HC16 | DNA dC->dU-editing enzyme APOBEC-3G | Enzyme | C00000619 | 0 / 0 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00000619
C00001180
C00001221
C00001232
C00001233 C00001238 C00007535 |
5465 | PPARA, NR1C1, PPAR, PPARalpha, hPPAR | peroxisome proliferator-activated receptor alpha |
C00001221
C00001228
C00001231
C00001232
C00001233 C00001238 C00030829 |
7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00000619
C00001180
C00001232
C00001233
C00002645 C00007535 |
213 | ALB, PRO0883, PRO0903, PRO1341 | albumin |
C00001232
C00001233
C00002645
C00002654
C00030878 |
10891 | PPARGC1A, LEM6, PGC-1(alpha), PGC-1v, PGC1, PGC1A, PPARGC1 | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
C00001213
C00001221
C00001228
C00001233
C00001238 |
128 | ADH5, ADH-3, ADHX, FALDH, FDH, GSH-FDH, GSNOR | alcohol dehydrogenase 5 (class III), chi polypeptide (EC:1.1.1.1 1.1.1.284) |
C00001213
C00001221
C00001231
C00030829
|
9619 | ABCG1, ABC8, WHITE1 | ATP-binding cassette, sub-family G (WHITE), member 1 |
C00001232
C00001233
C00001238
|
231 | AKR1B1, ADR, ALDR1, ALR2, AR | aldo-keto reductase family 1, member B1 (aldose reductase) (EC:1.1.1.21) |
C00000207
C00000357
C00000619
|
5468 | PPARG, CIMT1, GLM1, NR1C3, PPARG1, PPARG2, PPARgamma | peroxisome proliferator-activated receptor gamma |
C00000619
C00001180
C00001232
|
5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00000619
C00001221
C00001233
|
6348 | CCL3, G0S19-1, LD78ALPHA, MIP-1-alpha, MIP1A, SCYA3 | chemokine (C-C motif) ligand 3 |
C00000619
C00001233
C00001238
|
6647 | SOD1, ALS, ALS1, IPOA, SOD, hSod1, homodimer | superoxide dismutase 1, soluble (EC:1.15.1.1) |
C00000619
C00001180
C00001233
|
1571 | CYP2E1, CPE1, CYP2E, P450-J, P450C2E | cytochrome P450, family 2, subfamily E, polypeptide 1 (EC:1.14.13.n7) |
C00000619
C00001221
C00002645
|
1906 | EDN1, ET1, HDLCQ7, PPET1 | endothelin 1 |
C00001232
C00001233
C00001238
|
2938 | GSTA1, GST2, GSTA1-1, GTH1 | glutathione S-transferase alpha 1 (EC:2.5.1.18) |
C00000207
C00000619
C00002741
|
22949 | PTGR1, LTB4DH, PGR1, ZADH3 | prostaglandin reductase 1 (EC:1.3.1.48 1.3.1.74) |
C00000207
C00000619
|
7296 | TXNRD1, GRIM-12, TR, TR1, TRXR1, TXNR | thioredoxin reductase 1 (EC:1.8.1.9) |
C00000207
C00000619
|
847 | CAT | catalase (EC:1.11.1.6) |
C00000619
C00001232
|
1559 | CYP2C9, CPC9, CYP2C, CYP2C10, CYPIIC9, P450IIC9 | cytochrome P450, family 2, subfamily C, polypeptide 9 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
C00000619
C00001221
|
7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00000357
C00000619
|
6648 | SOD2, IPOB, MNSOD, MVCD6 | superoxide dismutase 2, mitochondrial (EC:1.15.1.1) |
C00000619
C00001180
|
199974 | CYP4Z1, CYP4A20 | cytochrome P450, family 4, subfamily Z, polypeptide 1 (EC:1.14.14.1) |
C00001221
C00001228
|
4609 | MYC, MRTL, MYCC, bHLHe39, c-Myc | v-myc avian myelocytomatosis viral oncogene homolog |
C00000357
C00001180
|
4846 | NOS3, ECNOS, eNOS | nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) |
C00000207
C00001232
|
5054 | SERPINE1, PAI, PAI-1, PAI1, PLANH1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
C00001232
C00001233
|
54659 | UGT1A3, UDPGT, UDPGT_1-3, UGT-1C, UGT1-03, UGT1.3, UGT1C | UDP glucuronosyltransferase 1 family, polypeptide A3 (EC:2.4.1.17) |
C00001213
C00001221
|
196 | AHR, bHLHe76 | aryl hydrocarbon receptor |
C00000619
C00001418
|
5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00000619
C00001180
|
3630 | INS, IDDM2, ILPR, IRDN, MODY10 | insulin |
C00001232
C00001233
|
581 | BAX, BCL2L4 | BCL2-associated X protein |
C00001180
C00001233
|
5226 | PGD, 6PGD | phosphogluconate dehydrogenase (EC:1.1.1.44) |
C00000207
C00000619
|
1728 | NQO1, DHQU, DIA4, DTD, NMOR1, NMORI, QR1 | NAD(P)H dehydrogenase, quinone 1 (EC:1.6.5.2) |
C00000207
C00000619
|
4501 | MT1X, MT-1l, MT1 | metallothionein 1X |
C00000619
C00001233
|
4502 | MT2A, MT2 | metallothionein 2A |
C00000207
C00001233
|
942 | CD86, B7-2, B7.2, B70, CD28LG2, LAB72 | CD86 molecule |
C00000619
C00030829
|
2950 | GSTP1, DFN7, FAEES3, GST3, GSTP, PI | glutathione S-transferase pi 1 (EC:2.5.1.18) |
C00000619
C00002741
|
2944 | GSTM1, GST1, GSTM1-1, GSTM1a-1a, GSTM1b-1b, GTH4, GTM1, H-B, MU, MU-1 | glutathione S-transferase mu 1 (EC:2.5.1.18) |
C00000619
C00002741
|
4199 | ME1, HUMNDME, MES | malic enzyme 1, NADP(+)-dependent, cytosolic (EC:1.1.1.40) |
C00000207
C00000619
|
1544 | CYP1A2, CP12, P3-450, P450(PA) | cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) |
C00000619
C00002645
|
1565 | CYP2D6, CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, CYPIID6, P450-DB1, P450C2D, P450DB1 | cytochrome P450, family 2, subfamily D, polypeptide 6 (EC:1.14.14.1) |
C00000619
C00002645
|
4097 | MAFG, hMAF | v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog G |
C00000207
C00000619
|
3162 | HMOX1, HMOX1D, HO-1, HSP32, bK286B10 | heme oxygenase (decycling) 1 (EC:1.14.99.3) |
C00000207
C00000619
|
3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00000619
C00002645
|
2936 | GSR | glutathione reductase (EC:1.8.1.7) |
C00000207
C00000619
|
2730 | GCLM, GLCLR | glutamate-cysteine ligase, modifier subunit (EC:6.3.2.2) |
C00000207
C00000619
|
57016 | AKR1B10, AKR1B11, AKR1B12, ALDRLn, ARL-1, ARL1, HIS, HSI | aldo-keto reductase family 1, member B10 (aldose reductase) (EC:1.1.1.2) |
C00000207
C00000619
|
1645 | AKR1C1, 2-ALPHA-HSD, 20-ALPHA-HSD, C9, DD1, DD1/DD2, DDH, DDH1, H-37, HAKRC, HBAB, MBAB | aldo-keto reductase family 1, member C1 (EC:1.3.1.20 1.1.1.149 1.1.1.112) |
C00000207
C00000619
|
8644 | AKR1C3, DD3, DDX, HA1753, HAKRB, HAKRe, HSD17B5, PGFS, hluPGFS | aldo-keto reductase family 1, member C3 (EC:1.3.1.20 1.1.1.188 1.1.1.239 1.1.1.64 1.1.1.112 1.1.1.357) |
C00000207
C00000619
|
2729 | GCLC, GCL, GCS, GLCL, GLCLC | glutamate-cysteine ligase, catalytic subunit (EC:6.3.2.2) |
C00000207
C00000619
|
2539 | G6PD, G6PD1 | glucose-6-phosphate dehydrogenase (EC:1.1.1.49) |
C00000207
C00000619
|
2512 | FTL, NBIA3 | ferritin, light polypeptide |
C00000207
C00000619
|
2235 | FECH, EPP, FCE | ferrochelatase (EC:4.99.1.1) |
C00000207
C00000619
|
567 | B2M | beta-2-microglobulin |
C00000619
C00001180
|
596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00000619
C00001233
|
2100 | ESR2, ER-BETA, ESR-BETA, ESRB, ESTRB, Erb, NR3A2 | estrogen receptor 2 (ER beta) |
C00000619
C00001180
|
1869 | E2F1, E2F-1, RBAP1, RBBP3, RBP3 | E2F transcription factor 1 |
C00000619
C00001232
|
6347 | CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, SCYA2, SMC-CF | chemokine (C-C motif) ligand 2 |
C00000619
C00001180
|
140809 | SRXN1, C20orf139, Npn3, SRX, SRX1 | sulfiredoxin 1 (EC:1.8.98.2) |
C00000207
C00000619
|
10203 | CALCRL, CGRPR, CRLR | calcitonin receptor-like |
C00000619
|
57102 | C12orf4 | chromosome 12 open reading frame 4 |
C00000619
|
6357 | CCL13, CKb10, MCP-4, NCC-1, NCC1, SCYA13, SCYL1 | chemokine (C-C motif) ligand 13 |
C00000619
|
6363 | CCL19, CKb11, ELC, MIP-3b, MIP3B, SCYA19 | chemokine (C-C motif) ligand 19 |
C00000619
|
699 | BUB1, BUB1A, BUB1L, hBUB1 | BUB1 mitotic checkpoint serine/threonine kinase (EC:2.7.11.1) |
C00000619
|
6349 | CCL3L1, 464.2, D17S1718, G0S19-2, LD78, LD78BETA, MIP1AP, SCYA3L, SCYA3L1 | chemokine (C-C motif) ligand 3-like 1 |
C00000619
|
6351 | CCL4, ACT2, AT744.1, G-26, HC21, LAG-1, LAG1, MIP-1-beta, MIP1B, MIP1B1, SCYA2, SCYA4 | chemokine (C-C motif) ligand 4 |
C00000619
|
729230 | CCR2, CC-CKR-2, CCR-2, CCR2A, CCR2B, CD192, CKR2, CKR2A, CKR2B, CMKBR2, MCP-1-R | chemokine (C-C motif) receptor 2 |
C00000619
|
1234 | CCR5, CC-CKR-5, CCCKR5, CCR-5, CD195, CKR-5, CKR5, CMKBR5, IDDM22 | chemokine (C-C motif) receptor 5 (gene/pseudogene) |
C00000619
|
1236 | CCR7, BLR2, CD197, CDw197, CMKBR7, EBI1 | chemokine (C-C motif) receptor 7 |
C00000619
|
948 | CD36, BDPLT10, CHDS7, FAT, GP3B, GP4, GPIV, PASIV, SCARB3 | CD36 molecule (thrombospondin receptor) |
C00000619
|
1385 | CREB1, CREB | cAMP responsive element binding protein 1 |
C00000619
|
1390 | CREM, CREM-2, ICER, hCREM-2 | cAMP responsive element modulator |
C00000619
|
1514 | CTSL, CATL, CTSL1, MEP | cathepsin L (EC:3.4.22.15) |
C00000619
|
2919 | CXCL1, FSP, GRO1, GROa, MGSA, MGSA-a, NAP-3, SCYB1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
C00000619
|
7852 | CXCR4, CD184, D2S201E, FB22, HM89, HSY3RR, LAP3, LCR1, LESTR, NPY3R, NPYR, NPYRL, NPYY3R, WHIM | chemokine (C-X-C motif) receptor 4 |
C00000619
|
1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00000619
|
1545 | CYP1B1, CP1B, CYPIB1, GLC3A, P4501B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) |
C00000619
|
1593 | CYP27A1, CP27, CTX, CYP27 | cytochrome P450, family 27, subfamily A, polypeptide 1 (EC:1.14.13.15) |
C00000619
|
1736 | DKC1, CBF5, DKC, DKCX, NAP57, NOLA4, XAP101 | dyskeratosis congenita 1, dyskerin |
C00000619
|
9787 | DLGAP5, DLG7, HURP | discs, large (Drosophila) homolog-associated protein 5 |
C00000619
|
654 | BMP6, VGR, VGR1 | bone morphogenetic protein 6 |
C00000619
|
1870 | E2F2, E2F-2 | E2F transcription factor 2 |
C00000619
|
1871 | E2F3, E2F-3 | E2F transcription factor 3 |
C00000619
|
1874 | E2F4, E2F-4 | E2F transcription factor 4, p107/p130-binding |
C00000619
|
1875 | E2F5, E2F-5 | E2F transcription factor 5, p130-binding |
C00000619
|
1876 | E2F6, E2F-6 | E2F transcription factor 6 |
C00000619
|
1959 | EGR2, AT591, CMT1D, CMT4E, KROX20 | early growth response 2 |
C00000619
|
133418 | EMB | embigin |
C00000619
|
2099 | ESR1, ER, ESR, ESRA, ESTRR, Era, NR3A1 | estrogen receptor 1 |
C00000619
|
9774 | BCLAF1, BTF, bK211L9.1 | BCL2-associated transcription factor 1 |
C00000619
|
2162 | F13A1, F13A | coagulation factor XIII, A1 polypeptide (EC:2.3.2.13) |
C00000619
|
26268 | FBXO9, FBX9, NY-REN-57, VCIA1, dJ341E18.2 | F-box protein 9 |
C00000619
|
2213 | FCGR2B, CD32, CD32B, FCG2, FCGR2, IGFR2 | Fc fragment of IgG, low affinity IIb, receptor (CD32) |
C00000619
|
10123 | ARL4C, ARL7, LAK | ADP-ribosylation factor-like 4C |
C00000619
|
2355 | FOSL2, FRA2 | FOS-like antigen 2 |
C00000619
|
55114 | ARHGAP17, MST066, MST110, MSTP038, MSTP066, MSTP110, NADRIN, PP367, PP4534, RICH1, RICH1B, WBP15 | Rho GTPase activating protein 17 |
C00000619
|
367 | AR, AIS, DHTR, HUMARA, HYSP1, KD, NR3C4, SBMA, SMAX1, TFM | androgen receptor |
C00000619
|
249 | ALPL, AP-TNAP, APTNAP, HOPS, TNAP, TNSALP | alkaline phosphatase, liver/bone/kidney (EC:3.1.3.1) |
C00000619
|
23460 | ABCA6, EST155051 | ATP-binding cassette, sub-family A (ABC1), member 6 |
C00000619
|
644076 | GLYCAM1 | glycosylation dependent cell adhesion molecule 1 (pseudogene) |
C00000619
|
2878 | GPX3, GPx-P, GSHPx-3, GSHPx-P | glutathione peroxidase 3 (plasma) (EC:1.11.1.9) |
C00000619
|
2932 | GSK3B | glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) |
C00000619
|
7412 | VCAM1, CD106, INCAM-100 | vascular cell adhesion molecule 1 |
C00002645
|
2994 | GYPB, CD235b, GPB, GPB.NY, GYPHe.NY, GpMiIII, HGpMiIII, HGpMiVI, HGpMiX, MNS, PAS-3, SS | glycophorin B (MNS blood group) |
C00000619
|
54497 | HEATR5B | HEAT repeat containing 5B |
C00000619
|
3091 | HIF1A, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1, PASD8, bHLHe78 | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
C00000619
|
3106 | HLA-B, AS, HLAB, SPDA1 | major histocompatibility complex, class I, B |
C00000619
|
3383 | ICAM1, BB2, CD54, P3.58 | intercellular adhesion molecule 1 |
C00002645
|
220988 | HNRNPA3, 2610510D13Rik, D10S102, FBRNP, HNRPA3 | heterogeneous nuclear ribonucleoprotein A3 |
C00000619
|
3381 | IBSP, BNSP, BSP, BSP-II, SP-II | integrin-binding sialoprotein |
C00000619
|
3422 | IDI1, IPP1, IPPI1 | isopentenyl-diphosphate delta isomerase 1 (EC:5.3.3.2) |
C00000619
|
7850 | IL1R2, CD121b, CDw121b, IL-1R-2, IL-1RT-2, IL-1RT2, IL1R2c, IL1RB | interleukin 1 receptor, type II |
C00000619
|
3575 | IL7R, CD127, CDW127, IL-7R-alpha, IL7RA, ILRA | interleukin 7 receptor |
C00000619
|
26034 | IPCEF1, PIP3-E, RP3-402L9.2 | interaction protein for cytohesin exchange factors 1 |
C00000619
|
3655 | ITGA6, CD49f, ITGA6B, VLA-6 | integrin, alpha 6 |
C00000619
|
3688 | ITGB1, CD29, FNRB, GPIIA, MDF2, MSK12, VLA-BETA, VLAB | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) |
C00000619
|
3741 | KCNA5, ATFB7, HCK1, HK2, HPCN1, KV1.5, PCN1 | potassium voltage-gated channel, shaker-related subfamily, member 5 |
C00000619
|
3759 | KCNJ2, ATFB9, HHBIRK1, HHIRK1, IRK1, KIR2.1, LQT7, SQT3 | potassium inwardly-rectifying channel, subfamily J, member 2 |
C00000619
|
9493 | KIF23, CHO1, KNSL5, MKLP-1, MKLP1 | kinesin family member 23 |
C00000619
|
23764 | MAFF, U-MAF, hMafF | v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog F |
C00000619
|
50848 | F11R, CD321, JAM, JAM1, JAMA, JCAM, KAT, PAM-1 | F11 receptor |
C00002645
|
7975 | MAFK, NFE2U, P18 | v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog K |
C00000619
|
28985 | MCTS1, MCT-1, MCT1 | malignant T cell amplified sequence 1 |
C00000619
|
6376 | CX3CL1, ABCD-3, C3Xkine, CXC3, CXC3C, NTN, NTT, SCYD1, fractalkine, neurotactin | chemokine (C-X3-C motif) ligand 1 |
C00002645
|
4257 | MGST1, GST12, MGST, MGST-I | microsomal glutathione S-transferase 1 (EC:2.5.1.18) |
C00000619
|
51318 | MRPL35, L35mt, MRP-L35 | mitochondrial ribosomal protein L35 |
C00000619
|
58475 | MS4A7, 4SPAN2, CD20L4, CFFM4, MS4A8 | membrane-spanning 4-domains, subfamily A, member 7 |
C00000619
|
9076 | CLDN1, CLD1, ILVASC, SEMP1 | claudin 1 |
C00001213
|
4084 | MXD1, BHLHC58, MAD, MAD1 | MAX dimerization protein 1 |
C00000619
|
4602 | MYB, Cmyb, c-myb, c-myb_CDS, efg | v-myb avian myeloblastosis viral oncogene homolog |
C00000619
|
10135 | NAMPT, 1110035O14Rik, PBEF, PBEF1, VF, VISFATIN | nicotinamide phosphoribosyltransferase (EC:2.4.2.12) |
C00000619
|
4780 | NFE2L2, NRF2 | nuclear factor, erythroid 2-like 2 |
C00000619
|
4790 | NFKB1, EBP-1, KBF1, NF-kB1, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, NFkappaB, p105, p50 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
C00000619
|
4161 | MC5R, MC2 | melanocortin 5 receptor |
C00001418
|
4927 | NUP88 | nucleoporin 88kDa |
C00000619
|
10606 | PAICS, ADE2, ADE2H1, AIRC, PAIS | phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase (EC:6.3.2.6 4.1.1.21) |
C00000619
|
5142 | PDE4B, DPDE4, PDE4B5, PDEIVB | phosphodiesterase 4B, cAMP-specific (EC:3.1.4.17) |
C00000619
|
4160 | MC4R | melanocortin 4 receptor |
C00001418
|
8301 | PICALM, CALM, CLTH, LAP | phosphatidylinositol binding clathrin assembly protein |
C00000619
|
5327 | PLAT, T-PA, TPA | plasminogen activator, tissue (EC:3.4.21.68) |
C00000619
|
5366 | PMAIP1, APR, NOXA | phorbol-12-myristate-13-acetate-induced protein 1 |
C00000619
|
4159 | MC3R, BMIQ9, MC3, MC3-R, OB20, OQTL | melanocortin 3 receptor |
C00001418
|
10935 | PRDX3, AOP-1, AOP1, HBC189, MER5, PRO1748, SP-22, prx-III | peroxiredoxin 3 (EC:1.11.1.15) |
C00000619
|
5733 | PTGER3, EP3, EP3-I, EP3-II, EP3-III, EP3-IV, EP3e, PGE2-R | prostaglandin E receptor 3 (subtype EP3) |
C00000619
|
4157 | MC1R, CMM5, MSH-R, SHEP2 | melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor) |
C00001418
|
405 | ARNT, HIF-1-beta, HIF-1beta, HIF1-beta, HIF1B, HIF1BETA, TANGO, bHLHe2 | aryl hydrocarbon receptor nuclear translocator |
C00001418
|
5996 | RGS1, 1R20, BL34, IER1, IR20 | regulator of G-protein signaling 1 |
C00000619
|
6157 | RPL27A, L27A | ribosomal protein L27a |
C00000619
|
50484 | RRM2B, MTDPS8A, MTDPS8B, P53R2 | ribonucleotide reductase M2 B (TP53 inducible) (EC:1.17.4.1) |
C00000619
|
6303 | SAT1, DC21, KFSD, KFSDX, SAT, SSAT, SSAT-1 | spermidine/spermine N1-acetyltransferase 1 (EC:2.3.1.57) |
C00000619
|
6383 | SDC2, CD362, HSPG, HSPG1, SYND2 | syndecan 2 |
C00000619
|
55752 | SEPT11 | septin 11 |
C00000619
|
6504 | SLAMF1, CD150, CDw150, SLAM | signaling lymphocytic activation molecule family member 1 |
C00000619
|
117247 | SLC16A10, MCT10, PRO0813, TAT1 | solute carrier family 16 (aromatic amino acid transporter), member 10 |
C00000619
|
6515 | SLC2A3, GLUT3 | solute carrier family 2 (facilitated glucose transporter), member 3 |
C00000619
|
64127 | NOD2, ACUG, BLAU, CARD15, CD, CLR16.3, IBD1, NLRC2, NOD2B, PSORAS1 | nucleotide-binding oligomerization domain containing 2 |
C00001221
|
1579 | CYP4A11, CP4Y, CYP4A2, CYP4AII | cytochrome P450, family 4, subfamily A, polypeptide 11 (EC:1.14.15.3) |
C00001221
|
6649 | SOD3, EC-SOD | superoxide dismutase 3, extracellular (EC:1.15.1.1) |
C00000619
|
1080 | CFTR, ABC35, ABCC7, CF, CFTR/MRP, MRP7, TNR-CFTR, dJ760C5.1 | cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (EC:3.6.3.49) |
C00030100
|
6772 | STAT1, CANDF7, ISGF-3, STAT91 | signal transducer and activator of transcription 1, 91kDa |
C00000619
|
6775 | STAT4, SLEB11 | signal transducer and activator of transcription 4 |
C00000619
|
6777 | STAT5B, STAT5 | signal transducer and activator of transcription 5B |
C00000619
|
7099 | TLR4, ARMD10, CD284, TLR-4, TOLL | toll-like receptor 4 |
C00000619
|
7128 | TNFAIP3, A20, OTUD7C, TNFA1P2 | tumor necrosis factor, alpha-induced protein 3 (EC:3.4.19.12) |
C00000619
|
7130 | TNFAIP6, TSG-6, TSG6 | tumor necrosis factor, alpha-induced protein 6 |
C00000619
|
8626 | TP63, AIS, B(p51A), B(p51B), EEC3, KET, LMS, NBP, OFC8, RHS, SHFM4, TP53CP, TP53L, TP73L, p40, p51, p53CP, p63, p73H, p73L | tumor protein p63 |
C00000619
|
162514 | TRPV3, OLMS, VRL3 | transient receptor potential cation channel, subfamily V, member 3 |
C00000619
|
25828 | TXN2, MT-TRX, MTRX, TRX2 | thioredoxin 2 |
C00000619
|
9970 | NR1I3, CAR, CAR1, MB67 | nuclear receptor subfamily 1, group I, member 3 |
C00030830
|
10587 | TXNRD2, SELZ, TR, TR-BETA, TR3, TRXR2 | thioredoxin reductase 2 (EC:1.8.1.9) |
C00000619
|
7358 | UGDH, GDH, UDP-GlcDH, UDPGDH, UGD | UDP-glucose 6-dehydrogenase (EC:1.1.1.22) |
C00000619
|
54658 | UGT1A1, BILIQTL1, GNT1, HUG-BR1, UDPGT, UDPGT_1-1, UGT1, UGT1A | UDP glucuronosyltransferase 1 family, polypeptide A1 (EC:2.4.1.17) |
C00000619
|
54575 | UGT1A10, UDPGT, UGT-1J, UGT1-10, UGT1.10, UGT1J | UDP glucuronosyltransferase 1 family, polypeptide A10 (EC:2.4.1.17) |
C00000619
|
54578 | UGT1A6, GNT1, HLUGP, HLUGP1, UDPGT, UDPGT_1-6, UGT1, UGT1A6S, UGT1F | UDP glucuronosyltransferase 1 family, polypeptide A6 (EC:2.4.1.17) |
C00000619
|
54577 | UGT1A7, UDPGT, UDPGT_1-7, UGT-1G, UGT1-07, UGT1.7, UGT1G | UDP glucuronosyltransferase 1 family, polypeptide A7 (EC:2.4.1.17) |
C00000619
|
54576 | UGT1A8, UDPGT, UDPGT_1-8, UGT-1H, UGT1-08, UGT1.8, UGT1A8S, UGT1H | UDP glucuronosyltransferase 1 family, polypeptide A8 (EC:2.4.1.17) |
C00000619
|
54600 | UGT1A9, HLUGP4, LUGP4, UDPGT, UDPGT_1-9, UGT-1I, UGT1-09, UGT1-9, UGT1.9, UGT1AI, UGT1I | UDP glucuronosyltransferase 1 family, polypeptide A9 (EC:2.4.1.17) |
C00000619
|
7366 | UGT2B15, HLUG4, UDPGT_2B8, UDPGT2B15, UDPGTH3, UGT2B8 | UDP glucuronosyltransferase 2 family, polypeptide B15 (EC:2.4.1.17) |
C00000619
|
7367 | UGT2B17, BMND12, UDPGT2B17 | UDP glucuronosyltransferase 2 family, polypeptide B17 (EC:2.4.1.17) |
C00000619
|
7421 | VDR, NR1I1 | vitamin D (1,25- dihydroxyvitamin D3) receptor |
C00000619
|
7709 | ZBTB17, MIZ-1, ZNF151, ZNF60, pHZ-67 | zinc finger and BTB domain containing 17 |
C00000619
|
759 | CA1, CA-I, CAB, Car1 | carbonic anhydrase I (EC:4.2.1.1) |
C00002654
|
760 | CA2, CA-II, CAC, CAII, Car2 | carbonic anhydrase II (EC:4.2.1.1) |
C00002654
|
19 | ABCA1, ABC-1, ABC1, CERP, HDLDT1, TGD | ATP-binding cassette, sub-family A (ABC1), member 1 |
C00001232
|
9429 | ABCG2, ABC15, ABCP, BCRP, BCRP1, BMDP, CD338, CDw338, EST157481, GOUT1, MRX, MXR, MXR1, UAQTL1 | ATP-binding cassette, sub-family G (WHITE), member 2 |
C00001232
|
335 | APOA1 | apolipoprotein A-I |
C00001232
|
338 | APOB, FLDB, LDLCQ4 | apolipoprotein B |
C00001232
|
1401 | CRP, PTX1 | C-reactive protein, pentraxin-related |
C00001232
|
1646 | AKR1C2, AKR1C-pseudo, BABP, DD, DD2, DDH2, HAKRD, HBAB, MCDR2, SRXY8 | aldo-keto reductase family 1, member C2 (EC:1.3.1.20 1.1.1.357) |
C00007535
|
501 | ALDH7A1, ATQ1, EPD, PDE | aldehyde dehydrogenase 7 family, member A1 (EC:1.2.1.3 1.2.1.8 1.2.1.31) |
C00000357
|
142 | PARP1, ADPRT, ADPRT_1, ADPRT1, ARTD1, PARP, PARP-1, PPOL, pADPRT-1 | poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) |
C00001232
|
5444 | PON1, ESA, MVCD5, PON | paraoxonase 1 (EC:3.1.1.2 3.1.8.1 3.1.1.81) |
C00001232
|
778733 |
C00001232
|
||
100136658 |
C00001232
|
||
5467 | PPARD, FAAR, NR1C2, NUC1, NUCI, NUCII, PPARB | peroxisome proliferator-activated receptor delta |
C00001232
|
5925 | RB1, OSRC, RB, p105-Rb, pRb, pp110 | retinoblastoma 1 |
C00001232
|
6256 | RXRA, NR2B1 | retinoid X receptor, alpha |
C00001232
|
221 | ALDH3B1, ALDH4, ALDH7 | aldehyde dehydrogenase 3 family, member B1 (EC:1.2.1.5) |
C00000357
|
6514 | SLC2A2, GLUT2 | solute carrier family 2 (facilitated glucose transporter), member 2 |
C00001232
|
6720 | SREBF1, SREBP-1c, SREBP1, bHLHd1 | sterol regulatory element binding transcription factor 1 |
C00001232
|
207 | AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) |
C00001233
|
218 | ALDH3A1, ALDH3, ALDHIII | aldehyde dehydrogenase 3 family, member A1 (EC:1.2.1.5) |
C00000357
|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00001233
|
840 | CASP7, CASP-7, CMH-1, ICE-LAP3, LICE2, MCH3 | caspase 7, apoptosis-related cysteine peptidase (EC:3.4.22.60) |
C00001233
|
1374 | CPT1A, CPT1, CPT1-L, L-CPT1 | carnitine palmitoyltransferase 1A (liver) (EC:2.3.1.21) |
C00001233
|
2876 | GPX1, GPXD, GSHPX1 | glutathione peroxidase 1 (EC:1.11.1.9) |
C00001233
|
3034 | HAL, HIS, HSTD | histidine ammonia-lyase (EC:4.3.1.3) |
C00001233
|
57817 | HAMP, HEPC, HFE2B, LEAP1, PLTR | hepcidin antimicrobial peptide |
C00001233
|
3481 | IGF2, C11orf43, IGF-II, PP9974 | insulin-like growth factor 2 (somatomedin A) |
C00001233
|
1432 | MAPK14, CSBP, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA | mitogen-activated protein kinase 14 (EC:2.7.11.24) |
C00001233
|
5599 | MAPK8, JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1, SAPK1c | mitogen-activated protein kinase 8 (EC:2.7.11.24) |
C00001233
|
5601 | MAPK9, JNK-55, JNK2, JNK2A, JNK2ALPHA, JNK2B, JNK2BETA, PRKM9, SAPK, SAPK1a, p54a, p54aSAPK | mitogen-activated protein kinase 9 (EC:2.7.11.24) |
C00001233
|
4493 | MT1E, MT1, MTD | metallothionein 1E |
C00001233
|
4494 | MT1F, MT1 | metallothionein 1F |
C00001233
|
4496 | MT1H, MT-0, MT-1H, MT-IH, MT1 | metallothionein 1H |
C00001233
|
217 | ALDH2, ALDH-E2, ALDHI, ALDM | aldehyde dehydrogenase 2 family (mitochondrial) (EC:1.2.1.3) |
C00000357
|
4843 | NOS2, HEP-NOS, INOS, NOS, NOS2A | nitric oxide synthase 2, inducible (EC:1.14.13.39) |
C00001233
|
3651 | PDX1, GSF, IDX-1, IPF1, IUF1, MODY4, PDX-1, STF-1 | pancreatic and duodenal homeobox 1 |
C00001233
|
29893 | PSMC3IP, GT198, HOP2, HUMGT198A, ODG3, TBPIP | PSMC3 interacting protein |
C00001233
|
23216 | TBC1D1, TBC, TBC1 | TBC1 (tre-2/USP6, BUB2, cdc16) domain family, member 1 |
C00001233
|
7351 | UCP2, BMIQ4, SLC25A8, UCPH | uncoupling protein 2 (mitochondrial, proton carrier) |
C00001233
|
4489 | MT1A, MT1, MT1S, MTC | metallothionein 1A |
C00000207
|
6566 | SLC16A1, HHF7, MCT, MCT1 | solute carrier family 16 (monocarboxylate transporter), member 1 |
C00000207
|
7295 | TXN, TRDX, TRX, TRX1 | thioredoxin |
C00000207
|
5243 | ABCB1, ABC20, CD243, CLCS, GP170, MDR1, P-GP, PGY1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) |
C00001180
|
1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00001180
|
1081 | CGA, CG-ALPHA, FSHA, GPHA1, GPHa, HCG, LHA, TSHA | glycoprotein hormones, alpha polypeptide |
C00001180
|
64581 | CLEC7A, BGR, CANDF4, CLECSF12, DECTIN1 | C-type lectin domain family 7, member A |
C00001180
|
2002 | ELK1 | ELK1, member of ETS oncogene family |
C00001180
|
8288 | EPX, EPO, EPP, EPX-PEN | eosinophil peroxidase (EC:1.11.1.7) |
C00001180
|
2623 | GATA1, ERYF1, GATA-1, GF-1, GF1, NF-E1, NFE1, XLANP, XLTDA, XLTT | GATA binding protein 1 (globin transcription factor 1) |
C00001180
|
2624 | GATA2, DCML, MONOMAC, NFE1B | GATA binding protein 2 |
C00001180
|
2993 | GYPA, CD235a, GPA, GPErik, GPSAT, HGpMiV, HGpMiXI, HGpSta(C), MN, MNS, PAS-2 | glycophorin A (MNS blood group) |
C00001180
|
10013 | HDAC6, CPBHM, HD6 | histone deacetylase 6 (EC:3.5.1.98) |
C00001180
|
8290 | HIST3H3, H3.4, H3/g, H3FT, H3t | histone cluster 3, H3 |
C00001180
|
121504 | HIST4H4, H4/p | histone cluster 4, H4 |
C00001180
|
3145 | HMBS, PBG-D, PBGD, PORC, UPS | hydroxymethylbilane synthase (EC:2.5.1.61) |
C00001180
|
3606 | IL18, IGIF, IL-18, IL-1g, IL1F4 | interleukin 18 (interferon-gamma-inducing factor) |
C00001180
|
3569 | IL6, BSF2, HGF, HSF, IFNB2, IL-6 | interleukin 6 (interferon, beta 2) |
C00001180
|
3725 | JUN, AP-1, AP1, c-Jun | jun proto-oncogene |
C00001180
|
10524 | KAT5, ESA1, HTATIP, HTATIP1, PLIP, TIP, TIP60, ZC2HC5, cPLA2 | K(lysine) acetyltransferase 5 (EC:2.3.1.48) |
C00001180
|
4254 | KITLG, FPH2, KL-1, Kitl, MGF, SCF, SF, SHEP7 | KIT ligand |
C00001180
|
4778 | NFE2, NF-E2, p45 | nuclear factor, erythroid 2 |
C00001180
|
11315 | PARK7, DJ-1, DJ1 | parkinson protein 7 |
C00001180
|
5553 | PRG2, BMPG, MBP, MBP1 | proteoglycan 2, bone marrow (natural killer cell activator, eosinophil granule major basic protein) |
C00001180
|
5742 | PTGS1, COX1, COX3, PCOX1, PES-1, PGG/HS, PGHS-1, PGHS1, PHS1, PTGHS | prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00001180
|
6732 | SRPK1, SFRSK1 | SRSF protein kinase 1 (EC:2.7.11.1) |
C00001180
|
6733 | SRPK2, SFRSK2 | SRSF protein kinase 2 (EC:2.7.11.1) |
C00001180
|
6427 | SRSF2, PR264, SC-35, SC35, SFRS2, SFRS2A, SRp30b | serine/arginine-rich splicing factor 2 |
C00001180
|
7040 | TGFB1, CED, DPD1, LAP, TGFB, TGFbeta | transforming growth factor, beta 1 |
C00001180
|
7043 | TGFB3, ARVD, ARVD1, TGF-beta3 | transforming growth factor, beta 3 |
C00001180
|
7096 | TLR1, CD281, TIL, TIL._LPRS5, rsc786 | toll-like receptor 1 |
C00001180
|
10333 | TLR6, CD286 | toll-like receptor 6 |
C00001180
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
#219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#103780 | Alcohol dependence |
P08172
P14416 P31645 |
#612069 | Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia; als10 |
Q13148
|
#614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
#300068 | Androgen insensitivity syndrome; ais |
P10275
|
#312300 | Androgen insensitivity, partial; pais |
P10275
|
#613546 | Aromatase deficiency |
P11511
|
#139300 | Aromatase excess syndrome; aexs |
P11511
|
#208900 | Ataxia-telangiectasia; at |
Q13315
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#601816 | Bilirubin, serum level of, quantitative trait locus 1; biliqtl1 |
P22309
|
#210900 | Bloom syndrome; blm |
P54132
|
#602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
%606641 | Body mass index; bmi |
P37231
|
#612560 | Bone mineral density quantitative trait locus 12; bmnd12 |
O75795
|
#600430 | Brachydactyly-mental retardation syndrome; bdmr |
P56524
|
#300615 | Brunner syndrome |
P21397
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#609338 | Carotid intimal medial thickness 1 |
P37231
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#114500 | Colorectal cancer; crc |
P84022
|
#300882 | Cornelia de lange syndrome 5; cdls5 |
Q9BY41
|
#614466 | Coronary heart disease, susceptibility to, 6; chds6 |
P08254
|
#218800 | Crigler-najjar syndrome, type i |
P22309
P22310 |
#606785 | Crigler-najjar syndrome, type ii |
P22309
P22310 |
#162800 | Cyclic neutropenia |
P08246
|
#612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
#119900 | Digital clubbing, isolated congenital |
P15428
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#133239 | Esophageal cancer |
P04637
|
#615363 | Estrogen resistance; estrr |
P03372
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#613659 | Gastric cancer |
P04626
|
#137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
#231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
#143500 | Gilbert syndrome |
P22309
P22310 |
#137800 | Glioma susceptibility 1; glm1 |
P04626
P37231 |
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#237900 | Hyperbilirubinemia, transient familial neonatal; hblrtfn |
P22309
|
#614300 | Hypermethioninemia due to adenosine kinase deficiency |
P55263
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#246300 | Leprosy, susceptibility to, 3; lprs3 |
O60603
|
#116920 | Leukocyte adhesion deficiency, type i; lad |
P05107
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#604367 | Lipodystrophy, familial partial, type 3; fpld3 |
P37231
|
#613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P00533
P04626 P04637 |
#608516 | Major depressive disorder; mdd |
P08172
|
#611162 | Malaria, susceptibility to |
P05362
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#174800 | Mccune-albright syndrome; mas |
P63092
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
%300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#259600 | Multicentric osteolysis, nodulosis, and arthropathy; mona |
P08253
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#159900 | Myoclonic dystonia |
P14416
|
#202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
#257200 | Niemann-pick disease, type a |
P17405
|
#607616 | Niemann-pick disease, type b |
P17405
|
#601665 | Obesity |
P32245
P37231 |
#164230 | Obsessive-compulsive disorder; ocd |
P31645
|
#604715 | Orthostatic intolerance |
P23975
|
#166350 | Osseous heteroplasia, progressive; poh |
P63092
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P04626
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
#172700 | Pick disease of brain |
P10636
|
#102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
#103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
#603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
#612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
#607276 | Resting heart rate, variation in |
P08588
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#600852 | Retinitis pigmentosa 17; rp17 |
P22748
|
#608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
#274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
#145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
#190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
#610379 | West nile virus, susceptibility to |
P51681
|
#309585 | Wilson-turner x-linked mental retardation syndrome; wts |
Q9BY41
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00344 | Leprosy |
O60603
(related)
|
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00017 | Esophageal cancer |
P00533
(related)
P04637 (related) P04637 (marker) P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04626 (related) P04637 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04626 (related) P04637 (related) |
H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) P04637 (related) P08253 (related) |
H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
H00042 | Glioma |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
P37231 (related) |
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) P04637 (related) Q92731 (marker) |
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
P11511 (related) |
H00019 | Pancreatic cancer |
P04626
(related)
P04637 (related) P04637 (marker) |
H00027 | Ovarian cancer |
P04626
(related)
P04637 (related) |
H00031 | Breast cancer |
P04626
(related)
P04626 (marker) P04637 (related) |
H00046 | Cholangiocarcinoma |
P04626
(related)
P04637 (related) P35354 (related) |
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
|
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
Q13315 (related) |
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) P08253 (related) P14780 (related) P35354 (related) |
H00029 | Vulvar cancer |
P04637
(related)
|
H00032 | Thyroid cancer |
P04637
(related)
P37231 (related) |
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
|
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00021 | Renal cell carcinoma |
P04637
(marker)
|
H00099 | Leukocyte adhesion deficiency (LAD) |
P05107
(related)
|
H00083 | Allograft rejection |
P05362
(related)
|
H00080 | Systemic lupus erythematosus |
P05362
(marker)
|
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00079 | Asthma |
P07550
(related)
|
H00100 | Neutropenic disorders |
P08246
(related)
|
H00472 | Torg-Winchester syndrome |
P08253
(related)
|
H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
H00024 | Prostate cancer |
P10275
(related)
|
H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
Q13148 (related) |
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H00794 | Aromatase excess syndrome |
P11511
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00479 | Metaphyseal dysplasias |
P14780
(related)
|
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H00137 | Niemann-Pick disease (NPD) typeA and B |
P17405
(related)
|
H00424 | Defects in the degradation of sphingomyelin |
P17405
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|
H00208 | Hyperbilirubinemia |
P22309
(related)
|
H00527 | Retinitis pigmentosa (RP) |
P22748
(related)
|
H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00409 | Type II diabetes mellitus |
P37231
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
Q99714 (related) |
H00094 | DNA repair defects |
P54132
(related)
Q13315 (related) |
H00296 | Defects in RecQ helicases |
P54132
(related)
|
H00561 | Brachydacytly-mental retardation syndrome and Smith-Magenis syndrome |
P56524
(related)
|
H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q03164
(related)
Q03164 (marker) |
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00064 | Ataxia telangiectasia (AT) |
Q13315
(related)
|
H00848 | Ataxia with ocular apraxia (AOA) |
Q13315
(related)
|
H01065 | Pentosuria |
Q7Z4W1
(related)
|
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q9NUW8
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D003072 | Cognition Disorders |
C00001238
C00001232 C00001233 |
D017449 | Dermatitis, Allergic Contact |
C00029456
C00030878 C00000619 |
D001943 | Breast Neoplasms |
C00002741
C00000619 |
D003877 | Dermatitis, Contact |
C00000619
C00000207 |
D006930 | Hyperalgesia |
C00002741
C00000619 |
D010146 | Pain |
C00000619
C00002654 |
D009374 | Neoplasms, Experimental |
C00002741
C00000619 |
D013274 | Stomach Neoplasms |
C00000619
|
D008114 | Liver Neoplasms, Experimental |
C00002741
|
D008107 | Liver Diseases |
C00030540
|
D011041 | Poisoning |
C00030829
|
D000236 | Adenoma |
C00029456
|
D008113 | Liver Neoplasms |
C00002741
|
D017453 | Dermatitis, Irritant |
C00029456
|
D007680 | Kidney Neoplasms |
C00029456
|
D012130 | Respiratory Hypersensitivity |
C00029456
|
D011658 | Pulmonary Fibrosis |
C00030755
|
D006529 | Hepatomegaly |
C00002741
|
D003128 | COMA |
C00001231
|
D002318 | Cardiovascular Diseases |
C00002645
|
D003873 | Dermatitis, Exfoliative |
C00002645
|
D006965 | Hyperplasia |
C00002645
|
D007674 | Kidney Diseases |
C00002645
|
D001836 | Body Weight Changes |
C00030878
|
D014202 | Tremor |
C00030878
|
D015431 | Weight Loss |
C00030878
|
D003328 | Coronary Thrombosis |
C00002741
|
D003875 | Drug Eruptions |
C00000619
|
D056486 | Drug-Induced Liver Injury |
C00000619
|
D006331 | Heart Diseases |
C00000619
|
D006461 | Hemolysis |
C00000619
|
D006967 | Hypersensitivity |
C00000619
|
D007249 | Inflammation |
C00000619
|
D008545 | Melanoma |
C00000619
|
D009361 | Neoplasm Invasiveness |
C00000619
|
D009362 | Neoplasm Metastasis |
C00000619
|
D009389 | Neovascularization, Pathologic |
C00000619
|
D009410 | Nerve Degeneration |
C00000619
|
D000707 | Anaphylaxis |
C00002741
|
D010149 | Pain, Postoperative |
C00000619
|
D010300 | Parkinson Disease |
C00000619
|
D011833 | Radiation Injuries, Experimental |
C00000619
|
D012481 | Salmonella Infections, Animal |
C00000619
|
D012878 | Skin Neoplasms |
C00000619
|
D013035 | Spasm |
C00000619
|
D013203 | Staphylococcal Infections |
C00000619
|
D008325 | Mammary Neoplasms, Experimental |
C00002741
|
D013276 | Stomach Ulcer |
C00000619
|
D014581 | Urticaria |
C00000619
|
D002583 | Uterine Cervical Neoplasms |
C00000619
|
D055371 | Acute Lung Injury |
C00001232
|
D000860 | Anoxia |
C00001232
|
D005234 | Fatty Liver |
C00001232
|
D006520 | Hepatitis, Animal |
C00001232
|
D007333 | Insulin Resistance |
C00001232
|
D055370 | Lung Injury |
C00001232
|
D011654 | Pulmonary Edema |
C00001232
|
D012128 | Respiratory Distress Syndrome, Adult |
C00001232
|
D000230 | Adenocarcinoma |
C00001180
|
D001008 | Anxiety Disorders |
C00001180
|
D008175 | Lung Neoplasms |
C00001180
|
D009139 | Musculoskeletal Abnormalities |
C00001180
|
D012021 | Reflex, Abnormal |
C00001180
|